REDUCE-IT: 25% Reduction in MACE With High-Dose EPA

High doses (4-g daily) of the omega-3 oil eicosapentaenoic acid (EPA) have shown a large benefit on cardiovascular events in the randomized, double-blind REDUCE-IT trial.

 

Related stories